Copyright Reports & Markets. All rights reserved.

Global Autoimmune Disease Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Autoimmune Disease Testing by Type
    • 1.3.1 Overview: Global Autoimmune Disease Testing Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Autoimmune Disease Testing Consumption Value Market Share by Type in 2025
    • 1.3.3 Instrument
    • 1.3.4 Reagent Consumables
  • 1.4 Global Autoimmune Disease Testing Market by Application
    • 1.4.1 Overview: Global Autoimmune Disease Testing Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Rheumatoid Arthritis
    • 1.4.3 Systemic Lupus Erythematosus
    • 1.4.4 Scleroderma
    • 1.4.5 Vasculitis
    • 1.4.6 Other
  • 1.5 Global Autoimmune Disease Testing Market Size & Forecast
  • 1.6 Global Autoimmune Disease Testing Market Size and Forecast by Region
    • 1.6.1 Global Autoimmune Disease Testing Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Autoimmune Disease Testing Market Size by Region, (2021-2032)
    • 1.6.3 North America Autoimmune Disease Testing Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Autoimmune Disease Testing Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Autoimmune Disease Testing Market Size and Prospect (2021-2032)
    • 1.6.6 South America Autoimmune Disease Testing Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Autoimmune Disease Testing Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 F.Hoffmann-La Roche Ltd
    • 2.1.1 F.Hoffmann-La Roche Ltd Details
    • 2.1.2 F.Hoffmann-La Roche Ltd Major Business
    • 2.1.3 F.Hoffmann-La Roche Ltd Autoimmune Disease Testing Product and Solutions
    • 2.1.4 F.Hoffmann-La Roche Ltd Autoimmune Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 F.Hoffmann-La Roche Ltd Recent Developments and Future Plans
  • 2.2 ZEus Scientific, Inc.
    • 2.2.1 ZEus Scientific, Inc. Details
    • 2.2.2 ZEus Scientific, Inc. Major Business
    • 2.2.3 ZEus Scientific, Inc. Autoimmune Disease Testing Product and Solutions
    • 2.2.4 ZEus Scientific, Inc. Autoimmune Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 ZEus Scientific, Inc. Recent Developments and Future Plans
  • 2.3 Thermo Fisher Scientific Inc.
    • 2.3.1 Thermo Fisher Scientific Inc. Details
    • 2.3.2 Thermo Fisher Scientific Inc. Major Business
    • 2.3.3 Thermo Fisher Scientific Inc. Autoimmune Disease Testing Product and Solutions
    • 2.3.4 Thermo Fisher Scientific Inc. Autoimmune Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
  • 2.4 QuestDiagnostics Incorporated
    • 2.4.1 QuestDiagnostics Incorporated Details
    • 2.4.2 QuestDiagnostics Incorporated Major Business
    • 2.4.3 QuestDiagnostics Incorporated Autoimmune Disease Testing Product and Solutions
    • 2.4.4 QuestDiagnostics Incorporated Autoimmune Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 QuestDiagnostics Incorporated Recent Developments and Future Plans
  • 2.5 Abbott
    • 2.5.1 Abbott Details
    • 2.5.2 Abbott Major Business
    • 2.5.3 Abbott Autoimmune Disease Testing Product and Solutions
    • 2.5.4 Abbott Autoimmune Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Abbott Recent Developments and Future Plans
  • 2.6 Ql Diagnostics Inc
    • 2.6.1 Ql Diagnostics Inc Details
    • 2.6.2 Ql Diagnostics Inc Major Business
    • 2.6.3 Ql Diagnostics Inc Autoimmune Disease Testing Product and Solutions
    • 2.6.4 Ql Diagnostics Inc Autoimmune Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Ql Diagnostics Inc Recent Developments and Future Plans
  • 2.7 Werfen
    • 2.7.1 Werfen Details
    • 2.7.2 Werfen Major Business
    • 2.7.3 Werfen Autoimmune Disease Testing Product and Solutions
    • 2.7.4 Werfen Autoimmune Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Werfen Recent Developments and Future Plans
  • 2.8 Trinity Biotech
    • 2.8.1 Trinity Biotech Details
    • 2.8.2 Trinity Biotech Major Business
    • 2.8.3 Trinity Biotech Autoimmune Disease Testing Product and Solutions
    • 2.8.4 Trinity Biotech Autoimmune Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Trinity Biotech Recent Developments and Future Plans
  • 2.9 KsL Beutner Laboratories (Beutner)
    • 2.9.1 KsL Beutner Laboratories (Beutner) Details
    • 2.9.2 KsL Beutner Laboratories (Beutner) Major Business
    • 2.9.3 KsL Beutner Laboratories (Beutner) Autoimmune Disease Testing Product and Solutions
    • 2.9.4 KsL Beutner Laboratories (Beutner) Autoimmune Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 KsL Beutner Laboratories (Beutner) Recent Developments and Future Plans
  • 2.10 Bio-Rad Laboratories
    • 2.10.1 Bio-Rad Laboratories Details
    • 2.10.2 Bio-Rad Laboratories Major Business
    • 2.10.3 Bio-Rad Laboratories Autoimmune Disease Testing Product and Solutions
    • 2.10.4 Bio-Rad Laboratories Autoimmune Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Bio-Rad Laboratories Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Autoimmune Disease Testing Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Autoimmune Disease Testing by Company Revenue
    • 3.2.2 Top 3 Autoimmune Disease Testing Players Market Share in 2025
    • 3.2.3 Top 6 Autoimmune Disease Testing Players Market Share in 2025
  • 3.3 Autoimmune Disease Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Autoimmune Disease Testing Market: Region Footprint
    • 3.3.2 Autoimmune Disease Testing Market: Company Product Type Footprint
    • 3.3.3 Autoimmune Disease Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Autoimmune Disease Testing Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Autoimmune Disease Testing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Autoimmune Disease Testing Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Autoimmune Disease Testing Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Autoimmune Disease Testing Consumption Value by Type (2021-2032)
  • 6.2 North America Autoimmune Disease Testing Market Size by Application (2021-2032)
  • 6.3 North America Autoimmune Disease Testing Market Size by Country
    • 6.3.1 North America Autoimmune Disease Testing Consumption Value by Country (2021-2032)
    • 6.3.2 United States Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Autoimmune Disease Testing Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Autoimmune Disease Testing Consumption Value by Type (2021-2032)
  • 7.2 Europe Autoimmune Disease Testing Consumption Value by Application (2021-2032)
  • 7.3 Europe Autoimmune Disease Testing Market Size by Country
    • 7.3.1 Europe Autoimmune Disease Testing Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 7.3.3 France Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Autoimmune Disease Testing Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Autoimmune Disease Testing Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Autoimmune Disease Testing Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Autoimmune Disease Testing Market Size by Region
    • 8.3.1 Asia-Pacific Autoimmune Disease Testing Consumption Value by Region (2021-2032)
    • 8.3.2 China Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 8.3.5 India Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Autoimmune Disease Testing Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Autoimmune Disease Testing Consumption Value by Type (2021-2032)
  • 9.2 South America Autoimmune Disease Testing Consumption Value by Application (2021-2032)
  • 9.3 South America Autoimmune Disease Testing Market Size by Country
    • 9.3.1 South America Autoimmune Disease Testing Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Autoimmune Disease Testing Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Autoimmune Disease Testing Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Autoimmune Disease Testing Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Autoimmune Disease Testing Market Size by Country
    • 10.3.1 Middle East & Africa Autoimmune Disease Testing Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Autoimmune Disease Testing Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Autoimmune Disease Testing Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Autoimmune Disease Testing Market Drivers
  • 11.2 Autoimmune Disease Testing Market Restraints
  • 11.3 Autoimmune Disease Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Autoimmune Disease Testing Industry Chain
  • 12.2 Autoimmune Disease Testing Upstream Analysis
  • 12.3 Autoimmune Disease Testing Midstream Analysis
  • 12.4 Autoimmune Disease Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Autoimmune Disease Testing market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Autoimmune Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Autoimmune Disease Testing market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Autoimmune Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Autoimmune Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Autoimmune Disease Testing market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Autoimmune Disease Testing
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Autoimmune Disease Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F.Hoffmann-La Roche Ltd, ZEus Scientific, Inc., Thermo Fisher Scientific Inc., QuestDiagnostics Incorporated, Abbott, Ql Diagnostics Inc, Werfen, Trinity Biotech, KsL Beutner Laboratories (Beutner), Bio-Rad Laboratories, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Autoimmune Disease Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Instrument
    Reagent Consumables
    Market segment by Application
    Rheumatoid Arthritis
    Systemic Lupus Erythematosus
    Scleroderma
    Vasculitis
    Other
    Market segment by players, this report covers
    F.Hoffmann-La Roche Ltd
    ZEus Scientific, Inc.
    Thermo Fisher Scientific Inc.
    QuestDiagnostics Incorporated
    Abbott
    Ql Diagnostics Inc
    Werfen
    Trinity Biotech
    KsL Beutner Laboratories (Beutner)
    Bio-Rad Laboratories
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Autoimmune Disease Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Autoimmune Disease Testing, with revenue, gross margin, and global market share of Autoimmune Disease Testing from 2021 to 2026.
    Chapter 3, the Autoimmune Disease Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Autoimmune Disease Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Autoimmune Disease Testing.
    Chapter 13, to describe Autoimmune Disease Testing research findings and conclusion.

    Buy now